RSS

TONX TON Strategy Co.

Mod: Add me as mod Asst: lajet
Last Post: 09/27/26
Followers: 270
Posts Today: 0
Views Today: 4182

TONX Stock Quote & Tools

$3.0600 ▼ -0.2400 (-7.27%) As of Oct 30, 4:00 PM EST
Last3.0600
$ Chg-0.2400
Open3.2400
High3.2400
Beta0.7263
Year High4.440
Market Cap168.52M
P/B Ratio0.44
EPS-1.91
Avg Vol (30d)261.6K
Volume569.3K
% Chg-7.27%
Prev Close3.3000
Low2.8600
VWAP3.09082
Year Low1.750
Total Shares55.07M
Shares Out55.07M
Float38.50M
ExchangeNCM
Technology Software & IT Services

TONX Stock Message Board Discussion

  1. acraft5

Top 10 Most Recent News Articles

Lakeland Builds Apartments; Screening Rules Cause Snags

Updated Category News Views 31

What's the Real Trouble in Lakeland? The Lakeland metro area surely ain't short on apartments after a colossal building frenzy. We're talking a solid 40% bump in just the past five years. You'd figure that'd be enough to solve any housing squeeze, right? But here's the kicker: vacancy rates are stuck at 11.8% — way over the national mean of 7.9%. Discounts like two...

Continue Reading
Infinix Unveils Global Flagship Store in Bali

Updated Category News Views 140

Innovating Retail: Infinix Takes a Bold Step Imagine stomping the well-trodden grounds of Bali and striking the jackpot of tech experiences. That's right, Infinix is making waves with its first global Flagship Concept Store. Unveiled on October 31st, this venture is a serious flex from the tech giant, and it's absolutely in no mood to play small. The Flagship Store: A Hub...

Continue Reading
Good Springs Earns Spot on Inc.'s 2026 Founder List

Updated Category News Views 5

There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....

Continue Reading
Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

Updated Category News Views 58

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

Continue Reading
ABVC BioPharma Raises $3.39M in Private Placement

Updated Category News Views 0

Dollar Signs and Big Plans: ABVC's Private Placement ABVC BioPharma just bagged $3.39 million through a private placement of senior convertible promissory notes. This ain’t your average financing move, folks. We’re talking original issue discount notes at a hefty 17.5%, maturing by June 2027. This deal takes the cake for today's big plays. Why This Matters to...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 40

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading
Fresha Teams with Klarna: Shaking Up Beauty Payments

Updated Category News Views 107

New Flexibility at the Beauty Checkout Hey, if you've ever paced back and forth considering signing up for that luxury self-care spree, well, Fresha’s latest move might just tip the scales. The beauty and wellness booking giant has partnered with Klarna, diving headfirst into the Buy Now, Pay Later (BNPL) craze. It's about time, right? Everyone loves a good spa session,...

Continue Reading
Fresenius, WuXi Biologics Blaze New Biosimilars Trail

Updated Category News Views 115

Fresenius Bets Big on Biopharma with WuXi Partnership A deal inked by Fresenius and WuXi Biologics is stirring up the biosimilars pot, aiming to widen Fresenius' grip on the market tenfold. We're not talking small potatoes here; we're talking up to 66 biosimilar molecules against a hefty backdrop of more than €370 billion in originator sales. It's as if they've said,...

Continue Reading
Young Talent Tackles IVF & Air Pollution Research

Updated Category News Views 24

Rookie Researcher: Jeffrey's Bold Leap at ASRM 2026 Teenagers typically have their heads buried in textbooks, but Jeffrey Huang's got his eyes set on something bigger. This high school junior from Taipei American School leaped onto the international stage at the American Society for Reproductive Medicine (ASRM) 2026, carrying a scientific study centred on a critical...

Continue Reading
AppLovin Faces Lawsuit Over AI Revenue Claims

Updated Category News Views 119

AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...

Continue Reading

Top 5 Most Recently Viewed Articles

Twin Disc Offers Insight at Upcoming Growth Conference

Updated Category News Views 101

Twin Disc's Upcoming Presentation at a Key Conference Twin Disc, Inc. (NASDAQ: TWIN) is gearing up to make a notable appearance at the upcoming Noble Capital Markets Emerging Growth Equity Conference. The event will take place in Boca Raton and is set for a pivotal moment when Chief Financial Officer Jeff Knutson takes the stage to share insights into the company's future...

Continue Reading
Keymed Biosciences Achieves Milestone with Stapokibart Approval

Updated Category News Views 85

Keymed Biosciences Inc. Receives Approval for Stapokibart Keymed Biosciences Inc. (HKEX: 02162) has made impressive advancements in dermatological treatments with the recent marketing approval of Stapokibart. This innovative therapy targets moderate-to-severe atopic dermatitis in adults and has received endorsement from the National Medical Products Administration, the...

Continue Reading
Harnessing AI for Next-Level Value Creation in Tech Firms

Updated Category News Views 215

Harnessing AI for Next-Level Value Creation in Tech Firms In today's fast-paced technological landscape, the integration of artificial intelligence (AI) is reshaping the operational dynamics of companies. Innovators are exploring the potential of AI to redefine services, optimize processes, and create new avenues for revenue generation. In a notable address, an industry...

Continue Reading
CoinShares Reveals Successful Exercise of Share Options

Updated Category News Views 229

CoinShares Executes Employee Share Options with Success CoinShares International Limited (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF) has made a significant announcement regarding its Employee Incentive Plan. Recently, the firm revealed that it has successfully exercised a total of 25,000 options from its Employee Incentive Plan - November 2020 Tranche. This is an...

Continue Reading
EverQuote's Impressive Q3 2025 Performance Highlights

Updated Category News Views 157

EverQuote Reports Strong Growth in Q3 2025 EverQuote, Inc. (Nasdaq: EVER), a prominent player in the online insurance marketplace, has revealed impressive financial results for the third quarter of 2025, showing significant growth across several critical metrics. Revenue surged by 20% year-over-year, reaching $173.9 million, reflecting the company's effective strategies...

Continue Reading